Marghescu Angela Ștefania

Ms. Marghescu Angela Ștefania

Research, National Institute of Pneumology Marius Nasta, Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
RCRoxana-Elena Cîrjaliu
Roxana-Elena Cîrjaliu
MDMariana Deacu
Mariana Deacu
IGIoana Gherghișan
Ioana Gherghișan
MȘMarghescu Angela Ștefania
Marghescu Angela Ștefania
MEManuela Enciu
Manuela Enciu
AFARIADNA PETRONELA FILDAN
ARIADNA PETRONELA FILDAN
This review brings together the current knowledge regarding the risk factors and the clinical, radiologic, and histological features of both post-COVID-19 pulmonary fibrosis (PCPF) and idiopathic pulmonary fibrosis (IPF), describing the similarities and the disparities between these two diseases, using numerous databases to identify relevant articles published in English through October 2022. This review would help clinicians, pathologists, and researchers make an accurate diagnosis, which can help identify the group of patients selected for anti-fibrotic therapies and future therapeutic perspectives.

16 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MȘMarghescu Angela Ștefania
Marghescu Angela Ștefania
SVSilviu Vlasceanu
Silviu Vlasceanu
Madalina (Preda) SolomonMadalina (Preda) Solomon
Madalina (Preda) Solomon
MȚMirela Țigău
Mirela Țigău
SDStefan Dumitrache-Rujinski
Stefan Dumitrache-Rujinski
MCMariana Costache
Mariana Costache
Pulmonary oncological pathologies are an important public health problem and the association with other pulmonary lesions may pose difficulties in diagnosis and staging or require different treatment options. To address this complexity, we conducted a retrospective observational study at the Marius Nasta Institute of Pneumophthisiology, Bucharest, Romania. Our study focused on patients admitted in 2019 with non-small-cell lung carcinoma and associated pulmonary lesions identified through surgical resection specimens. Among the 314 included patients, multiple pulmonary nodules were observed on macroscopic examination, with 12% (N = 37) exhibiting nonmalignant etiologies upon microscopic examination. These findings underscore the challenge of preoperative staging. Patients with coexisting nonmalignant lesions were similar in age, smoking habits, and professional or environmental exposure by comparison with those who presented only malignant lesions. The presentation of coexisting malignant and nonmalignant lesions may pose difficulties in diagnosing and staging pulmonary cancer.

7 January 2024 in Medicina
Verified
Journal Article
Open access
PDF file
MȘMarghescu Angela Ștefania
Marghescu Angela Ștefania
DLDiana Gabriela Leonte
Diana Gabriela Leonte
DRDANIEL ALEXANDRU RADU
DANIEL ALEXANDRU RADU
EMElena Doina Măgheran
Elena Doina Măgheran
ATAdrian Vasilică Tudor
Adrian Vasilică Tudor
MCMariana Costache
Mariana Costache
Lung cancer is among the most common oncological diseases regarding incidence and mortality, with most of these having epithelial origins. Pathological reporting of these tumors is conducted according to the 5th edition of the World Health Organisation (WHO) classification of thoracic tumours. This study aims to draw the pathologist’s attention to four rare, atypical microscopic aspects that some of the most common types of lung malignancies reveal upon standard evaluation (hematoxylin-eosin stain) that make histopathological diagnosis challenging: acantholytic, pseudoangiosarcomatous, signet ring cell, and clear cell features. Each of these aspects was exemplified by a case diagnosed in the pathology department of the “Marius Nasta” Institute. Furthermore, we analyzed the classification dynamics of different WHO editions and used PubMed to review articles written in English and published in the last eleven years on this subject. Pathologists should be familiar with these unusual aspects to avoid misdiagnoses and to ensure the correct classification of tumors, which is extremely important because these tumor phenotypes have been associated with specific molecular alterations and a worse clinical evolution. There is a need to clarify the histogenesis and associated genetic mutations, given the fact that the rarity of these tumor phenotypes makes their study difficult. Some authors consider these to be overlapping entities; however, we do not encourage this, as they may exhibit different prognoses and various molecular alterations with important therapeutic implications. The signet ring cell feature was associated with ALK rearrangement in lung adenocarcinoma; thus, these patients can benefit from tailored therapy with ALK-tyrosine kinase inhibitors (ALK-TKI). Recent studies associated clear cell morphology with FGFR3-TACC3 fusion, suggesting that patients with this diagnosis may be potentially eligible for FGFR inhibitors. We described, for the first time, the pseudoangiosarcomatous pattern in a case of lung adenocarcinoma; to our knowledge this aspect has only been described until now in the context of squamous cell carcinomas.

28 February 2024 in Medicina
Verified
Journal Article
Open access
PDF file
SVSilviu Vlasceanu
Silviu Vlasceanu
Beatrice MahlerBeatrice Mahler
Beatrice Mahler
MȘMarghescu Angela Ștefania
Marghescu Angela Ștefania
IBIoana Anca Badarau
Ioana Anca Badarau
Horațiu MoldovanHorațiu Moldovan
Horațiu Moldovan
CSCornel Savu
Cornel Savu
Background and Objectives: The mainstay treatment of non-small-cell lung carcinoma is still surgery, but its impact on survival beyond nine years has never been reported/analysed in Romania. Therefore, we studied the clinical characteristics and the short- and long-term survival of a population of 1369 patients diagnosed and treated in a single institution, with the variables included in the database being collected retrospectively. Materials and Methods: In this paper, we aimed to study a number of factors that might influence prognosis and survival in non-small bronchopulmonary carcinoma. Consequently, we analysed a series of parameters such as the age of patients, their sex, the histopathological type, the tumour stage, the presence of bronchial invasion, and the completeness of surgical resection. Results: All patients underwent major lung resection for curative purposes (pneumonectomy, lobectomy, or bilobectomy) between January 2015 and January 2023. The vital status of patients included in the study was obtained by checking the DGEP (General Directorate for Persons Record) database and verifying the reporting of “non-deceased” by the hospital administrative database, as well as by telephone interviews (with patients or their relatives). On univariate analysis, predictors of worse survival were the following: male sex (the hazard of death was 1.54 times higher in men); pT (compared to pT1 tumours, pT2 tumours have a 1.60 times higher hazard of death, pT3 tumours have a 2.16 times higher hazard, and pT4 tumours have a 2.97 times higher hazard); maximum tumour size (a 10 mm increase in tumour size is associated with a 10% increase in the hazard of death); the degree of differentiation (compared to patients with G1 tumours, those with G3 tumours have a 2.16 times higher hazard of death); resectability (compared to R0, R1 B+ has a 1.84 times higher hazard of death, R1 V+ has a 1.82 times higher hazard of death, and R1 B+&V+ has a 2.40 times higher hazard of death). Conclusions: As a result, long-term survival can be achieved after complete surgery for NSCLC, and factors that classically predict overall survival suggest that both the initial tumour aggressiveness and host characteristics act beyond the period usually considered in oncology.

29 September 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Beatrice MahlerBeatrice Mahler
Beatrice Mahler
IMIoana Madalina Moșteanu
Ioana Madalina Moșteanu
RBRaluca Bobocea
Raluca Bobocea
INIris Negoescu
Iris Negoescu
LMLeonard Florentin Mircea
Leonard Florentin Mircea
MȘMarghescu Angela Ștefania
Marghescu Angela Ștefania
A 66-year-old man, a 40-year smoker, was diagnosed with rheumatoid arthritis in 2018. He was treated for one year with methotrexate, and, later in 2020, he was diagnosed with interstitial pulmonary fibrosis. In 2022, treatment with nintedanib was initiated, with clinical improvement being indicated but without showing a functional or imaging benefit. The evolution of the disease was rapidly progressive and unfavorable, with death occurring due to pulmonary thromboembolism. Following the autopsy, triple lesions of the RA at the lung level were confirmed: interstitial, of the NSIP type with a fibrosing character at the level of the lower airways of the bilateral bronchiectasis type, and vascular damage due to pulmonary thromboembolism secondary to chronic inflammation.

14 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
ILIustina Leonte
Iustina Leonte
KIKarina Ivanov
Karina Ivanov
MȘMarghescu Angela Ștefania
Marghescu Angela Ștefania
RMRadu Matache
Radu Matache
VNValeria Florica Negru
Valeria Florica Negru
Beatrice MahlerBeatrice Mahler
Beatrice Mahler
We present the case of a 35-year-old patient without pathological history who developed hemopneumothorax due to altitude barotrauma during a commercial airline flight. The computed tomography (CT) of the chest identified the presence of right hydropneumothorax and emphysema “blebs” and bubbles. After the therapeutic insertion of a drain tube, the patient returned to the country by land transport. Three weeks later, he was diagnosed with right-sided pleurisy based on a CT scan with contrast material. A surgical intervention was then performed, and three biopsy samples were taken; the histopathological result highlighted suggestive elements for the diagnosis of desquamative interstitial pneumonia (DIP).